Wisconsin Alumni Research Foundation

Technology

Washed Platelet Extract

UW-Madison researchers have developed a washed platelet extract with increased platelet growth factor concentration and decreased total protein relative to platelet rich plasma, and methods of making ...
Learn More
Jacques Galipeau, Sabrina Brounts, Andrea Pennati | P190172US03

Technology

Synthetic Protein For Inducing Immune Tolerance

The present invention from UW Madison researchers is a fusion protein made of the full length PDL-1 transmembrane protein and full length IDO cytosolic protein which the inventors termed PIDO. These t...
Learn More
Jacques Galipeau, Pradyut Paul | P200100US02

Technology

UW researchers have identified a molecule commonly used as a vaccine adjuvant to add to the combination of radiation therapy and checkpoint inhibitor treatment to drive the immune system’s response ...
Learn More
Zachary Morris, Justin Jagodinsky | P220308WO01

Technology

Broadly protective influenza B virus vaccines

UW-Madison researchers have developed a series of mutant influenza B viruses that incorporate mutations in the HA1 protein that cause the virus to react with sera generated via exposure to the opposit...
Learn More
Yoshihiro Kawaoka, Gabriele Neumann | P220144US02

Technology

MUTANT ACE2 PROTEINS AND METHODS OF USING SAME

UW-Madison researchers have identified novel ACE2 mutants having enhanced activity and/or specificity in hydrolyzing angiotensin II. ACE2 (angiotensin converting enzyme 2) is a key metalloprotease of ...
Learn More
Philip Romero, Peter Heinzelman | P210188WO01

Technology

RECOMBINANT MULTIVALENT INFLUENZA VIRUSES

The present invention relates to a novel bivalent coronavirus/influenza virus vaccine (called CoroFlu). The vaccine comprises a coronavirus antigen (a secreted version of the spike (S) protein of SARS...
Learn More
Yoshihiro Kawaoka, Gabriele Neumann | P200263US02

WARF